IGF-1 changes after brain bleed and recovery
Part of Brain & nervous system, Heart & circulation clinical trials.
This study is looking at how a protein called IGF-1 changes in the blood after a brain bleed (intracerebral hemorrhage). Researchers want to see if these changes can help predict how well you will recover.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- Your stroke caused at least a moderate level of weakness (NIHSS score of 5 or more).
- You did not have lasting problems from a previous stroke or brain injury.
- You arrived at the hospital within 72 hours of your symptoms starting.
- Your body mass index (BMI) is 28 or lower.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people who come to the emergency room with a bleeding stroke (called intracerebral hemorrhage). It aims to learn more about the condition by studying blood tests and brain scans, to find ways to improve outcomes.
This study is testing a way to predict how well people will recover after a brain bleed (intracerebral hemorrhage). It uses information from the first 24 hours to help doctors and families understand the chances of getting better.
This study looks for markers in your blood and brain scans that may help doctors better understand and predict outcomes after a spontaneous brain bleed. It is for people with high blood pressure who have had a bleed within the last three days.
This study looks at what happens to people after a bleed in the brain. It will help doctors understand how people recover, so they can improve care for future patients.
This study tests if giving a human growth hormone can help older adults recover from a serious brain injury. It is for patients who have low protein levels in their blood, which may slow down healing.
This study tests whether a GLP-1 receptor agonist (a diabetes/weight-loss medication) can help reduce brain damage and improve recovery after a specific type of spontaneous brain bleed. The medication may reduce inflammation and protect brain tissue in the early hours after bleeding.
Hear when a new Insulin-Like Growth Factor I trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.